Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2026 to Dec 2027
    • Site contacts updated at 2 of 2 sites
    v23
  2. Lead sponsor: Timothy Chuter, MD to Warren J. Gasper, MD
    • Site contacts updated at 2 of 2 sites
    v22
  3. Re-verified, no change to tracked fieldsv21
  4. Site contacts updated at 2 of 2 sitesv20
  5. Primary and study completion dates pushed to Dec 2026v19
Show 17 earlier versionsHide 17 earlier versions
  1. Lead sponsor: University of California, San Francisco to Timothy Chuter, MD
    • Primary completion date: Dec 2020 to Dec 2021
    • Study completion date: Dec 2020 to Jun 2022
    v18
  2. Phase: Phase 1/2 to Not applicablev17
  3. Re-verified, no change to tracked fieldsv16
  4. Enrollment target: 200 to 250
    • Study completion date: Dec 2020
    v15
  5. Publications: 30 to 31v14
  6. Site contacts updated at 2 of 2 sites
    • Publications: 29 to 30
    v13
  7. Primary completion date: Dec 2018 to Dec 2020v12
  8. Enrollment target: 140 to 200
    • Site contacts updated at 2 of 2 sites
    • Publications: 22 to 29
    v11
  9. Site contacts updated at 1 of 2 sites
    • Study arms: 0 to 1
    v10
  10. Primary completion date: Dec 2014 to Dec 2018v9
  11. Enrollment target: 120 to 140
    • Eligibility criteria expanded, about 10 words
    v8
  12. Enrollment target: 55 to 120
    • Site contacts updated at 2 of 2 sites
    v7
  13. Primary completion date: Jan 2009 to Dec 2014v6
  14. 2 versions Re-verified since Jun 9, 2008, no change to tracked fieldsv4-v5
  15. Primary completion date: Jan 2009v3
  16. Publications: 11 to 22v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
Trial Details
NCT Number NCT00483249
Lead Sponsor Warren J. Gasper, MD
Conditions
(from sponsor)		 Thoracoabdominal Aortic Aneurysm, Paravisceral Abdominal Aortic Aneurysm
Related terms Aneurysm, Aortic Aneurysm, Thoracoabdominal
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov